Cantrell Drug Company recalls Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 732…
- Recall date
- July 14, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1066-2017
- FDA classification
- Class II
- Brand / firm
- Cantrell Drug Company
- Sold / distributed
- Nationwide within the US
Why it was recalled
Lack of Sterility Assurance.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-16
Get recall alerts
Free email alert whenever Cantrell Drug Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cantrell Drug Company